Package Insert: Information for the Patient
Aripiprazol TAD 30mg Tablets EFG
Read this package insert carefully before starting to take this medication, as it contains important information for you.
1.What is Aripiprazol TAD and how is it used
2.What you need to knowbeforestarting totake Aripiprazol TAD
3.How to take Aripiprazol TAD
4.Possible adverse effects
5.Storage of Aripiprazol TAD
6. Contents of the package and additional information
Aripiprazol TADcontains the active ingredient aripiprazol andbelong to a group of medicines called antipsychotics.It is used to treat adults and adolescents 15 years of age or older who suffer from a condition characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and monotony of emotional and behavioral state.People in this state may also feel depressed, guilty, anxious, or tense.
Aripiprazol TADtabletsare used to treat adults and adolescents 13 years of age or older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing much less sleep than usual, speaking very quickly with flight of ideas, and sometimes, severe irritability.In adults, it also prevents this situation in patients who have responded to treatment with aripiprazol.
Do not take Aripiprazol TAD:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Patients have reported cases of thoughts and behaviors of suicide during treatment with aripiprazol. Inform your doctor immediately if you have thoughts or intentions of suicide.
Before starting treatment with Aripiprazol TAD, tell your doctor if you have:
If you notice that you are gaining weight, developing unusual movements, experiencing drowsiness that interferes with your daily normal activities, having difficulty swallowing, or presenting allergic symptoms, please inform your doctor.
If you are an elderly person and suffer from dementia (loss of memory and other mental abilities), you or the person who cares for you or your family should inform your doctor if you have ever had a stroke or "mini" stroke.
Talk to your doctor immediately if you have thoughts or feelings of harming yourself. Cases of patients who experience thoughts and behaviors of suicide during treatment with aripiprazol have been reported.
Talk to your doctor immediately if you notice numbness or stiffness of the muscles with high fever, sweating, altered mental state, or very fast or irregular heartbeat.
Inform your doctor if you, your family, or caregiver notice that you are developing impulses or urges to behave in an unusual way in you and that you cannot resist the impulse, instinct, or temptation to carry out certain activities that may harm you or others. This is known as impulse control disorder and may include behaviors such as addiction to gambling, excessive intake or spending, abnormally high sex drive, or excessive concern about an increase in sexual thoughts and feelings.
Your doctor may consider adjusting or interrupting the dose.
Aripiprazol may cause drowsiness, low blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which could cause falls. Caution should be taken, especially if you are an elderly patient or have weakness.
Children and adolescents
Do not use this medication in children and adolescents under 13 years old.It is unknown if it is safe and effective in these patients.
Other medications and Aripiprazol TAD
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including over-the-counter medications.
Medications that lower blood pressure: aripiprazol may increase the effect of medications used to lower blood pressure. Make sure to inform your doctor if you are using any medication to control blood pressure.
If you are using this medication with any other medication, it may mean that your doctor needs to change your aripiprazol dose. It is especially important to mention to your doctor the following:
These medications may increase the risk of adverse effects or reduce the effect of Aripiprazol TAD; if you observe any unusual symptoms when taking any of these medications with Aripiprazol TAD, inform your doctor.
Medications that increase serotonin levels are generally used to treat diseases that include depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
These medications may increase the risk of adverse effects; if you observe any unusual symptoms when taking any of these medications with Aripiprazol TAD, inform your doctor.
Aripiprazol TAD with food, drinks, and alcohol
This medication can be taken regardless of meals.
Alcohol consumption should be avoided.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor before using this medication.
The following symptoms may occur in newborn babies, from mothers who have been treated with aripiprazol in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, contact your doctor.
If you are taking Aripiprazol TAD, your doctor will discuss with you whether you should breastfeed your baby, considering the benefit of your treatment and the benefit of breastfeeding for your baby. If you are being treated with Aripiprazol TAD, do not breastfeed. Talk to your doctor about the best way to feed your baby if you are taking this medication.
Driving and operating machinery
During treatment with aripiprazol, dizziness and vision problems (see section 4) may occur.
This should be taken into account when requiring maximum attention, for example, when driving or operating machinery.
Aripiprazol TAD contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose for adults is 15mg once a day.However, your doctor may prescribe lower and higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
Thetreatmentshould start with the oral solution (liquid) at a low dose.
The dose can be gradually increased tothe recommended dose for adolescents of 10 mg once a day.However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
Theappropriateformulations(e.g.,1mg/mlsolution)ofAripiprazolTAD are not available. A suitable alternative product with the same active ingredient should be used.
If you estimate that the effect of Aripiprazol TAD is too strong or too weak, inform your doctor or pharmacist.
Try to take Aripiprazol TAD at the same time everyday.You can take it with or without food.Always take the tablets with water and swallow them whole.
Even if you feel better,do not alter or interrupt the daily dose of Aripiprazol TAD without consulting your doctor first.
If you take more Aripiprazol TAD than youshould
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91.562.04.20, indicating the medication and the amount ingested.
Patients who have taken too much aripiprazol have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or nearest hospital immediately if you experience any of the above symptoms.
If you forget to take Aripiprazol TAD
If you forget a dose, take the missed dose as soon as you remember, but do not take a double dose to compensate for the missed dose.
If you interrupt treatment with Aripiprazol TAD
Do not stop treatment just because you feel better. It is essential to continue taking Aripiprazol TAD for the time your doctor has indicated.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Frequent side effects (may affect up to 1 in 10 patients):
Less frequent side effects (may affect up to 1 in 100 patients):
The following side effects have been reported during the post-marketing phase of oral aripiprazole, but the frequency of occurrence is unknown:
Inform your doctor if you experience any of these behaviors; they will explain how to manage or reduce the symptoms.
In elderly patients with dementia, there have been reported a higher number of fatal cases while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other side effects in children and adolescents
Adolescents aged 13 years or older experienced side effects similar in frequency and type to those of adults, except for drowsiness, involuntary spasms or contractions, restlessness, and fatigue, which were very frequent (may affect more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when getting up from lying down or sitting, which were frequent (may affect more than 1 in 100 patients).
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de medicamentos de Uso Humanoor:https://www.notificaram.es/. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. This will help protect the environment.
Composition of Aripiprazole TAD
Appearance of the product and contents of the package
Aripiprazol TAD 30 mg tablets are pale pink, round, biconvex, with beveled edges, with possible darker and lighter points, and engraved with «A30» on one face (diameter: 9 mm, thickness: 3.9–5.3 mm).
Each package contains 14, 28, 30, 50, 56, 60, 84, 90, 98, or 100 tablets in blisters.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany.
Responsible manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia.
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany.
For more information about this medicine, please contact the local representative of the marketing authorization holder:
KRKA Pharmaceutical, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain.
This medicine is authorized in the member states of the European Economic Area with the following names:
Member state name | Medicine name |
Hungary | Aripiprazole Krka 30 mg tabletta |
Belgium | Aripiprazole Krka 30 mg tabletten |
Chile | Aripiprazole Krka 30 mg |
Spain | Aripiprazol TAD 30 mg comprimidos EFG |
France | Aripiprazole Krka 30 mg comprimé |
Ireland | Aripiprazole Krka 30 mg tablets |
Italy | Aripiprazolo Krka |
Netherlands | Aripiprazole Focus 30 mg tabletten |
Last review date of this leaflet: May 2023
For detailed information about this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.